方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| 周-塔拉莱法× | 等效线分析× | 群体药效学模型× | |
|---|---|---|---|
| 领域 | 药理学 | 药理学 | 药理学 |
| 方法族 | Process / pipeline | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1983 | 1926 | 1992 |
| 提出者≠ | Ting-Chao Chou and Paul Talalay | Salvatore Loewe | Lewis Sheiner and Stephen Roush |
| 类型≠ | synergy quantification | synergy quantification | dose-response modeling |
| 开创性文献≠ | Chou, T. C., & Talalay, P. (1983). Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Advances in Enzyme Regulation, 22, 27-55. DOI ↗ | Loewe, S. (1926). Die Mischtoxizität. Zeitschrift für Experimentelle Pathologie und Therapie, 24, 315-334. link ↗ | Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗ |
| 别名 | CI method, Chou method, median-effect analysis | isobol, combination index, synergy testing | PopPD, population PD, hierarchical PD modeling |
| 相关 | 3 | 3 | 3 |
| 摘要≠ | The Chou-Talalay method is a quantitative framework for analyzing drug interactions, developed by Ting-Chao Chou and Paul Talalay in 1983. It combines median-effect principle with the combination index (CI) to provide rigorous, model-independent assessment of synergistic, additive, or antagonistic drug effects. | Isobologram analysis is a graphical and quantitative method for detecting and classifying drug interactions, developed by Salvatore Loewe in 1926. It uses dose-response data from two drugs applied individually and in combination to determine whether their interaction is additive, synergistic, or antagonistic. | Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction. |
| ScholarGate数据集 ↗ |
|
|
|